At DOCERE, we are committed to advancing pharma innovation by staying at the forefront of generative AI solutions. By harnessing the transformative power of this technology, we’re shaping the future of healthcare and pharmaceutical industries.

Our mission is clear: to enhance patient and provider care experiences by integrating cutting-edge digital and Gen AI solutions that deliver real impact.

1. Focusing on Solutions Instead of Identifying Real Unmet Needs.

The temptation to jump straight into developing a shiny new GEN AI solution is strong, but it’s a common pitfall. Without first understanding the unmet needs of your Healthcare providers or patients/caregivers target audience, even the most advanced solutions can fail.

Take, for example, a project we led to create an AI agent for a pharmaceutical company’s physician clients. Initially, the scope included training the model with vast amounts of data and equipping it with multiple features and services. However, after in-depth consultations with doctors, we discovered that many of these features were unnecessary and are burdensome to update frequently often due to many updates by global and local guidelines, the training scope overly ambitious.

By focusing on their real needs, we streamlined the development process, avoiding significant delays and delivering a tailored solution faster. These critical insights were only possible because we took the time to truly understand the physicians’ challenges and goals.

2. Addressing a Challenge That Might Be a Real Need for a Healthcare Provider but Isn’t Painful Enough for Their Healthcare Organization.

If the problem your solution aims to solve doesn’t address a significant challenge for the healthcare organization as a whole, adoption will stall.

Generative AI solutions must focus on high-priority pain points—issues that directly affect HCPs’ workflows, decision-making, or patient outcomes. More importantly, these solutions need to align with the healthcare organization’s vision, as well as its IT restrictions and boundaries.

Whether it’s optimizing treatment pathways, reducing administrative bottlenecks, or supporting complex data analysis, the problem must be both pressing enough to inspire action and valuable enough to justify integration with the organization’s data sources. Additionally, private patient data constraints must always be respected. Remember, impactful solutions are born from addressing meaningful challenges that resonate across all levels of the organization.

The absence of clearly articulated success metrics is a prevalent issue in generative AI projects, particularly within the fast-evolving landscape of 2024, where generative AI initiatives often lack established benchmarks for comparison. Success is not merely an endpoint but a continuous process of evaluation and refinement.

An essential first step involves the development of a minimum viable product (MVP), enabling iterative testing and refinement based on actionable feedback. Engaging HCP early adopters during this phase is critical, as their insights not only validate the product’s relevance but also facilitate smoother integration and broader adoption within the healthcare ecosystem. These early collaborators often emerge as champions of the technology, driving its acceptance across the organization.

Additionally, defining specific, data-driven success metrics is paramount. For example, measurable goals might include a 20% increase in the efficiency of patient-HCP interactions or a 50% reduction in time spent on manual documentation processes. By establishing robust benchmarks and tracking progress against these targets, organizations can ensure that generative AI solutions deliver tangible, scalable improvements.

3.    Avoiding Consultation with the Right Partners

Generative AI in pharma is not just about using new technology—it requires seamlessly integrating these innovations into a highly regulated and intricate system. Success relies on collaborating with professionals who deeply understand the industry’s regulatory requirements, the operational dynamics of pharmaceutical companies, and the technological constraints specific to healthcare organizations.

Equally critical is possessing expertise in designing and implementing AI tools effectively. Partnering with the right experts ensures your solution aligns with industry standards, addresses real-world challenges, and complies with essential regulatory requirements. By working with specialists in both pharma and AI, you can identify the best ways to apply these tools, uncover innovative opportunities, and scale your project to meet the evolving demands of the healthcare ecosystem.

________________________________________

At DOCERE, We’re Here to Help

Avoiding these common mistakes is essential to building generative AI solutions that drive meaningful change in the pharma industry. At DOCERE, we’ve developed proven frameworks to help our partners overcome challenges, validate ideas, and execute impactful projects with confidence.

Let us support your journey to innovation. Together, we’ll deliver life-changing solutions that elevate the healthcare industry and unlock new possibilities for patients and providers alike.

Office@docere-cx.com.il